Paragonix to Unveil New Organ Preservation Data at 2026 American Transplant Congress
Event summary
- Paragonix will present new clinical data on its liver and kidney preservation systems at the 2026 American Transplant Congress, including one oral presentation and five posters.
- The research focuses on real-world post-transplant patient outcomes using Paragonix’s LIVERguard and KidneyVault devices.
- Paragonix will host an industry symposium discussing innovation in organ preservation and transplant access.
- The event takes place June 20-24, 2026, in Boston, Massachusetts.
The big picture
Paragonix’s presentation at the 2026 American Transplant Congress underscores the growing importance of advanced organ preservation technologies in improving transplant outcomes. The company’s focus on evidence-based innovation aligns with broader industry trends toward enhancing organ utilization and patient care. As a Getinge company, Paragonix benefits from broader resources to scale its clinical registries and transplant services.
What we're watching
- Clinical Validation
- How the new data will impact adoption of Paragonix’s preservation systems in transplant centers.
- Market Expansion
- Whether Paragonix can sustain growth in organ preservation technology market.
- Regulatory Dynamics
- The pace at which Paragonix can expand its FDA-cleared and CE-marked devices globally.